The structure-based design, synthesis and biological evaluation of DNA-binding bisintercalating bisanthrapyrazole anticancer compounds

Improved protein–ligand docking using GOLD

Marcel L. Verdonk, Jason C. Cole, Michael J. Hartshorn et al. · Proteins Structure Function and Bioinformatics · 2003 · 3K citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II

K M Tewey, Thomas C. Rowe, Liu Yang et al. · Science · 1984 · 1.5K citations

Medicine, Molecular Biology, Pharmacology +17

Theoretical calculations of the helix–coil transition of DNA in the presence of large, cooperatively binding ligands

James D. McGhee · Biopolymers · 1976 · 308 citations

Natural Sciences, Biophysics, Molecular Biology +16

Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias

H. D. Hollis Showalter, Judith L. Johnson, Jeanne M. Hoftiezer et al. · Journal of Medicinal Chemistry · 1987 · 99 citations

Medicine, Oncology, Pharmacology +8

Topoisomerase II Inhibition and Cytotoxicity of the Anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute Preclinical Antitumor Drug Discovery Screen

François Leteurtre, Glenda Kohlhagen, Kenneth D. Paull et al. · JNCI Journal of the National Cancer Institute · 1994 · 75 citations

Medicine, Oncology, Pharmacology +15